The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells (Q35078248)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells |
scientific article |
Statements
1 reference
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells (English)
1 reference
Zeev Estrov
1 reference
William G Wierda
1 reference
Susan O'Brien
1 reference
Michael J Keating
1 reference
Neil E Kay
1 reference
Mariela Sivina
1 reference
Brian J Lannutti
1 reference
Jan A Burger
1 reference
Julia Hoellenriegel
1 reference
Stefania Fiorcari
1 reference
Wells S Brown
1 reference
Bradley W McIntyre
1 reference
Wei Ding
1 reference
23 December 2013
1 reference
1 reference
8
1 reference
12
1 reference
e83830
1 reference
23 December 2013
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference